Such alterations included the significant increase in the effector memory (EM) CD4 T cells in the primary and secondary tumors, and a significant increase of EM CD8 T cells in the secondary tumor, suggesting a heightened presence of T cells primed for immediate immune responses against the tumor. The gene discussed is CD4; the disease is neoplasm.